Charming Medical Ltd
corporate_fare Company Profile
Charming Medical Ltd (NASDAQ:MCTA) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 8 items for MCTA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-05, rated 9/10. Across its 8 most recent items scored 7 or higher, the top rating is 10/10, with 6 rated 8 or above. Recent SEC coverage for MCTA spans 6-K, 20-F, SCHEDULE 13D.
Recent high-impact activity:
- Charming Medical Confirms Nasdaq Delisting; Trading Suspends Nov. 9 Absent Appeal
- Nasdaq Sets Nov. 9 Delisting Date; Shares Halted Pending Appeal
- Charming Medical FY2026: Revenue Slides 23%, Stock Still Halted, Material Weaknesses Flagged
- Charming Medical dismantles dual-class shares, CEO locks up stake, and adopts U.S. governance standards
- Charming Medical Appoints Audit Expert Mei Cai to Board, Tsui Resigns
Financial Snapshot
Short Interest & Short Volume
FINRA reported short interest of 552,890 shares in MCTA as of the October 30, 2026 settlement, a 3.8% decrease from the prior period.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.
Insider Transactions
MCTA files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.